Anxiety Treatment

Clear the fog of anxiety. A different pathway for chronic, refractory anxiety.

Anxiety Treatment

For people whose anxiety hasn’t responded to SSRIs, SNRIs or CBT — the kind that doesn’t have a clear trigger and is just there, every day, in your chest, your stomach, your sleep. Our consultant-led IV ketamine programme in London works through a different mechanism. Proposed mechanisms are under investigation; evidence and expected response differ by condition.

Consultant-Led IV Ketamine
For Refractory Anxiety
Daily Monitoring Between Sessions

How ketamine is thought to act in anxiety — a different proposed mechanism.

SSRIs and SNRIs act on serotonin. Ketamine is thought to act on the glutamate system. Proposed mechanisms are under investigation; evidence and expected response differ by condition.

Calms the Hyperactive Amygdala

Proposed mechanisms are under investigation; evidence and expected response differ by condition.

Restores Prefrontal Control

Proposed mechanisms are under investigation; evidence and expected response differ by condition.

Rebuilds Synaptic Plasticity

Proposed mechanisms are under investigation; evidence and expected response differ by condition.

Resets the Stress Response

Effects on the stress response are under investigation

Outcomes are monitored using validated clinical measures.

What treatment actually looks like.

Every step is consultant-led. Every session is monitored. And between sessions, we track how you’re responding daily — not at your next appointment three months from now.

1 icon

Consultant Assessment

A consultant psychiatrist reviews your medical history, anxiety presentation, and previous treatments. We screen for anything that would make treatment unsafe and take baseline measures on validated scales (GAD-7, HAM-A) so we can track your response objectively.

2 icon

Preparation

You’ll fast for 4–6 hours before your session and arrange transport home. On arrival you’re settled in a private treatment room — dim lighting, quiet, comfortable — before your consultant confirms the plan with you.

3 icon

IV Infusion

Ketamine is delivered intravenously over 40–60 minutes at a subanaesthetic dose (typically 0.5 mg/kg), titrated to your weight and response. Heart rate, blood pressure and oxygen saturation are monitored throughout by a consultant anaesthetist.

4

Recovery & Debrief

You’ll rest in the clinic for 30–60 minutes as the acute effects wear off. Most people are back to their baseline within a few hours. Before you leave, we debrief the session and confirm the plan for the days ahead.

5

The Programme & Follow-Up

A full course is typically 6–8 sessions across 3–4 weeks. Between sessions, daily WhatsApp check-ins and validated scales let your consultant adjust the plan in real time. Booster sessions are scheduled based on how long your response holds.

Refractory Anxiety.

Chronic, treatment-resistant anxiety that hasn’t responded to medication or therapy. The kind that doesn’t have a clear trigger — it’s just there, every day, in your chest, your stomach, your sleep, your decision-making.

Who this is for

How we help

Proposed mechanisms are under investigation; evidence and expected response differ by condition.

Refractory  Anxiety

Consultant-led from day one

Your treatment is planned and delivered by a consultant psychiatrist and consultant anaesthetist — not delegated to junior clinicians.

Daily monitoring between sessions

Short WhatsApp check-ins plus validated clinical scales give your consultant real-time visibility of how you're responding — and let them adjust the plan session by session.

A programme designed to hold

The full course is 6–8 sessions across 3–4 weeks, with booster sessions timed to your individual response. Response varies between patients and long-term durability is uncertain.

Step out of the loop of chronic worry.

If anxiety medication and therapy haven’t given you lasting relief, the next step is a short eligibility check or a free, no-pressure call with our team.

IV ketamine is an unlicensed (off-label) prescription treatment for anxiety. It is not approved by the MHRA, FDA or NICE for this indication. Response varies between patients, side effects and risks are possible, and long-term outcomes remain uncertain. Treatment is delivered following individual medical and psychiatric assessment, and each treatment session is administered by a consultant.